Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- SEC CIK
- 0001615258
No open-market purchases or sales filed in the past year.
Current role at each company
- NATR Natures Sunshine Products Inc10% Owneras of Jun 27, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Shanghai Fosun Pharmaceutical (Group) Co., Ltd. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 27, 2025 (view filing)4:27 PM ET | Jun 27 | Same day | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. and 1 other10% Owner | SSale | −2.85M | $11.46 | −$32.7M | −100.0%0 after | |
| Oct 17, 2024 (view filing) | Oct 15 | 2 days | Shanghai Fosun Pharmaceutical (Group) Co., Ltd.10% Owner | SSale | −2.30K | $13.02 | −$29.9K | −3.5%64.2K after | |
| Oct 15, 2024 (view filing) | Oct 1-14 | 14 daysLate | Shanghai Fosun Pharmaceutical (Group) Co., Ltd.10% Owner | SSale | −10.9K | $13.33 | −$145.2K | −14.1%66.5K after | 6 lots |